US company to develop tissue matching technique:
This article was originally published in Clinica
Genetic MicroSystems has received a grant from the US National Cancer Institute to develop a new system for matching organ and bone marrow donors and recipients using its DNA microarray analysis technology. The microarray technology could reduce the cost and time associated with tissue typing and may also be useful for other applications that require simultaneous analysis of moderate to large numbers of DNA sequence variants, said the Woburn, Massachusetts-based company.
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.